Structure-Function Analysis of Mycobacterium tuberculosis Drug Target Cytochrome P450 125 (CYP125) Enzyme Family

Area of Science:

• Biochemistry
• Structural Biology
• Drug Discovery

Background:

• Tuberculosis remains a global health threat, necessitating novel drug targets.
• Cytochrome P450 CYP125A1 from Mycobacterium tuberculosis is a validated target for anti-TB drug development.
• Understanding structure-activity relationships of CYP125 enzymes is key for designing specific inhibitors.

Purpose of the Study:

• To analyze crystal structures of CYP125 family enzymes.
• To elucidate factors governing substrate specificity and catalytic roles of amino acids.
• To guide the design of specific CYP125A1 inhibitors for novel anti-TB drugs.

Main Methods:

• Analysis of 21 crystal structures of CYP125 family enzymes.
• Investigating active site cavity shape and its influence on substrate binding.
• Examining interactions between CYP125A enzymes and various ligands, including substrates and inhibitors.

Main Results:

• Identified unique letter-box and funnel-shaped active site cavity in CYP125A1.
• Determined that cavity shape dictates specificity for substrates like cholesterol.
• Observed distinct binding patterns for substrates and indole-derived inhibitors, including type I and II interactions.

Conclusions:

• The study provides comprehensive structure-function insights into CYP125A enzymes.
• Active site architecture is critical for substrate specificity and ligand interactions.
• Findings facilitate the rational design of targeted CYP125A1 inhibitors for new anti-tuberculosis therapies.